fda warning about compounded semaglutide Warns on Certain Forms of FDA is moving to restrict
Description
Ro, the leading direct-to-patient healthcare company, today announced a research collaboration with Amgen to study barriers to care and patients' treatment experience
Side effects with different GLP-1 drugs may vary from person to person.
A parasitic infection that causes explosive diarrhea is spreading across the United States, including Georgia
Meet the winners and read about their accomplishments.
A new study hints that weight-loss drugs might also affect how you metabolize alcohol.
